Clinical efficacy of new JAK inhibitors under development. Just more of the same?
R Westhovens - Rheumatology, 2019 - academic.oup.com
Janus kinase inhibition is promising in the treatment of RA, with already two oral drugs
marketed. New compounds are under investigation that are more selective for Janus kinase …
marketed. New compounds are under investigation that are more selective for Janus kinase …
[PDF][PDF] Clinical efficacy of new JAK inhibitors under development. Just more of the same?
R Westhovens - Rheumatology, 2019 - lirias.kuleuven.be
Janus kinase inhibition is promising in the treatment of RA, with already two oral drugs
marketed. New compounds are under investigation that are more selective for Janus kinase …
marketed. New compounds are under investigation that are more selective for Janus kinase …
[HTML][HTML] Clinical efficacy of new JAK inhibitors under development. Just more of the same?
R Westhovens - Rheumatology (Oxford, England), 2019 - ncbi.nlm.nih.gov
Janus kinase inhibition is promising in the treatment of RA, with already two oral drugs
marketed. New compounds are under investigation that are more selective for Janus kinase …
marketed. New compounds are under investigation that are more selective for Janus kinase …
[引用][C] Clinical efficacy of new JAK inhibitors under development. Just more of the same?
R Westhovens - Rheumatology, 2019 - cir.nii.ac.jp
Clinical efficacy of new JAK inhibitors under development. Just more of the same? | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Clinical efficacy of new JAK inhibitors under development. Just more of the same?
R Westhovens - Rheumatology (Oxford, England), 2019 - pubmed.ncbi.nlm.nih.gov
Janus kinase inhibition is promising in the treatment of RA, with already two oral drugs
marketed. New compounds are under investigation that are more selective for Janus kinase …
marketed. New compounds are under investigation that are more selective for Janus kinase …
Clinical efficacy of new JAK inhibitors under development. Just more of the same?
R Westhovens - Rheumatology (Oxford, England), 2019 - europepmc.org
Janus kinase inhibition is promising in the treatment of RA, with already two oral drugs
marketed. New compounds are under investigation that are more selective for Janus kinase …
marketed. New compounds are under investigation that are more selective for Janus kinase …
[PDF][PDF] Clinical efficacy of new JAK inhibitors under development. Just more of the same?
R Westhovens - Rheumatology, 2019 - pdfs.semanticscholar.org
Janus kinase inhibition is promising in the treatment of RA, with already two oral drugs
marketed. New compounds are under investigation that are more selective for Janus kinase …
marketed. New compounds are under investigation that are more selective for Janus kinase …
Clinical efficacy of new JAK inhibitors under development. Just more of the same?
R Westhovens - Rheumatology, 2019 - search.ebscohost.com
Janus kinase inhibition is promising in the treatment of RA, with already two oral drugs
marketed. New compounds are under investigation that are more selective for Janus kinase …
marketed. New compounds are under investigation that are more selective for Janus kinase …